Khashayar Esfahani
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Tofacitinib for the Treatment of Refractory Immune-related Colitis from Checkpoint Inhibitor Therapy- TRICK Study (NCT04768504) | Khashayar Esfahani | 2022-03-22 |
Track Khashayar Esfahani automatically
Every clearance here is in the API, with alerts when new ones post.